Home › Funds › Hikari Power Ltd › OCUL

Hikari Power Ltd position in OCUL

OCULAR THERAPEUTIX INC · Health Care

Hikari Power Ltd reported holding 17,000 shares of OCUL (OCULAR THERAPEUTIX INC) in its Q3 2026 13F filing — a position valued at US$130K, representing 0.03% of its reported portfolio and ranking #34 among its reported holdings. Hikari Power Ltd has disclosed OCUL holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)17.00K sh
Reported value held$130.00K
Portfolio Weight0.03%
First reportedQ3 2023
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Hikari Power Ltd's OCUL position evolved

Hikari Power Ltd first disclosed a stake in OCUL in Q3 2023 at 17,000 shares (US$53K). The position peaked in Q4 2025 at 17,000 shares, worth US$206K. Across 13 filings, Hikari Power Ltd held the position steady without any share-count change. The most recent filing (Q3 2026) shows 17,000 shares valued at US$130K.

Quarter by quarter

QuarterSharesValueChange
Q3 2023 17.00K $53.00K New
Q4 2023 17.00K $76.00K Hold
Q1 2024 17.00K $155.00K Hold
Q2 2024 17.00K $116.00K Hold
Q3 2024 17.00K $148.00K Hold
Q4 2024 17.00K $145.00K Hold
Q1 2025 17.00K $125.00K Hold
Q2 2025 17.00K $158.00K Hold
Q3 2025 17.00K $199.00K Hold
Q4 2025 17.00K $206.00K Hold
Q1 2026 17.00K $144.00K Hold
Q2 2026 17.00K $167.00K Hold
Q3 2026 17.00K $130.00K Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About OCUL and 13F data

OCUL (OCULAR THERAPEUTIX INC) is a Health Care company. 38 other funds we track also report a position in OCUL — the largest reported positions include Deep Track Capital, LP (US$193.3M), Avoro Capital Advisors LLC (US$123.1M), Venrock Adviser, LLC (US$101.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding OCUL

All OCUL fund holders →

FAQ

How long has Hikari Power Ltd held OCUL?

Hikari Power Ltd has disclosed OCUL holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Hikari Power Ltd's current position in OCUL?

As of Q3 2026, Hikari Power Ltd holds 17.00K shares of OCUL (OCULAR THERAPEUTIX INC), valued at $130.00K, representing 0.03% of its reported portfolio and ranking #34.

Has Hikari Power Ltd been buying or selling OCUL?

In the latest 13F filing (Q3 2026), Hikari Power Ltd held unchanged its position in OCUL. The position peaked in Q4 2025 at 17.00K shares.

Which other funds hold OCUL?

Other major institutional holders of OCUL include Deep Track Capital, LP, Avoro Capital Advisors LLC, Venrock Adviser, LLC, among 38 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.